Research ExplorerScientific StaffNicolaus-Martin Kröger Publications

Prof. Dr. ID: 37856

Nicolaus-Martin Kröger

Head of Clinic

graph of relations
Affiliations
751 - 776 out of 776Page size: 50

Publications

  1. 2006

  2. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

    Kröger, N., Shimoni, A., Zabelina, T., Schieder, H., Panse, J., Ayuketang Ayuk, F., Wolschke, C., Renges, H., Dahlke, J., Atanackovic, D., Nagler, A. & Zander, A. R., 2006, In: BONE MARROW TRANSPL. 37, 4, p. 339-344 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.

    Donk, V. D., Kröger, N., Kröger, N., Hegenbart, U., Corradini, P., Miguel, S., Jesus, F., Goldschmidt, H., Perez-Simon, J. A., Zijlmans, M., Ayuketang Ayuk, F., Montefusco, V., Ayuk, F. A., Oers, V., Marinus, H. J., Nagler, A., Verdonck, L. F. & Lokhorst, H. M., 2006, In: BLOOD. 107, 8, p. 3415-3416 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes.

    de Witte, T., Brand, R., van Biezen, A., Delforge, M., Biersack, H., Or, R., Meloni, G., Bandini, B., Sierra, J., Kröger, N., Gratwohl, A. & Niederwieser, D., 2006, In: HAEMATOLOGICA. 91, 6, p. 750-756 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2005

  6. Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells

    Fang, L., Fehse, B., Engel, M., Zander, A. & Kröger, N., 15.02.2005, In: TRANSPLANTATION. 79, 3, p. 369-371 3 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  7. Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.

    Thiele, J., Kvasnicka, H. M., Dietrich, H., Stein, G., Hann, M., Kaminski, A., Rathjen, N., Metz, K. A., Beelen, D. W., Ditschkowski, M., Zander, A. & Kröger, N., 2005, In: HISTOL HISTOPATHOL. 20, 3, p. 879-889 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

    Shimoni, A., Kröger, N-M., Zabelina, T., Ayuketang Ayuk, F., Hardan, I., Yeshurun, M., Shem-Tov, N., Avigdor, A., Ben-Bassat, I., Zander, A. & Nagler, A., 2005, In: LEUKEMIA. 19, 1, p. 7-12 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2004

  10. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

    Kröger, N-M., Schilling, G., Einsele, H., Liebisch, P., Shimoni, A., Nagler, A., Perez-Simon, J. A., Miguel, S., Jesus, F., Kiehl, M., Fauser, A., Schwerdtfeger, R., Wandt, H., Sayer, H. G., Myint, H., Zabelina, T., Zabelina, T., Dierlamm, J., Hinke, A. & Zander, A., 2004, In: BLOOD. 103, 11, p. 4056-4061 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

    Kröger, N-M., Shimoni, A., Zagrivnaja, M., Ayuketang Ayuk, F., Lioznov, M., Schieder, H., Renges, H-H., Fehse, B., Zabelina, T., Nagler, A. & Zander, A., 2004, In: BLOOD. 104, 10, p. 3361-3363 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

    Kiehl, M. G., Kraut, L., Schwerdtfeger, R., Hertenstein, B., Remberger, M., Kröger, N., Stelljes, M., Bornhaeuser, M., Martin, H., Scheid, C., Ganser, A., Zander, A. R., Kienast, J., Ehninger, G., Hoelzer, D., Diehl, V., Fauser, A. A. & Ringden, O., 2004, In: J CLIN ONCOL. 22, 14, p. 2816-2825 14.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

    Kröger, N-M., Perez-Simon, J. A., Myint, H., Klingemann, H., Shimoni, A., Nagler, A., Martino, R., Alegre, A., Tomas, J. F., Schwerdtfeger, R., Kiehl, M., Fauser, A., Sayer, H. G., Leon, A., Beyer, J., Zabelina, T., Ayuketang Ayuk, F., Miguel, S., Jesus, F., Brand, R. & Zander, A., 2004, In: BIOL BLOOD MARROW TR. 10, 10, p. 698-708 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2003

  15. Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.

    Fehse, N., Fehse, B., Kröger, N-M., Zabelina, T., Freiberger, P., Krüger, W., Kabisch, H., Erttmann, R. & Zander, A., 2003, In: J HEMATOTH STEM CELL. 12, 2, p. 237-242 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).

    Kröger, N-M., Einsele, H., Wolff, D., Casper, J., Freund, M., Derigs, G., Wandt, H., Schäfer-Eckart, K., Wittkowsky, G., Schmitz, N., Krüger, W., Zabelina, T., Renges, H., Ayuketang Ayuk, F., Krüll, A. & Zander, A., 2003, In: BONE MARROW TRANSPL. 31, 11, p. 973-979 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2002

  18. Molecular methods for detection and quantification of myeloma cells after bone marrow transplantation: comparison between real-time quantitative and nested PCR

    Tögel, F., Kröger, N., Korioth, F., Fehse, B. & Zander, A. R., 12.2002, In: J HEMATOTH STEM CELL. 11, 6, p. 971-976 6 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  19. Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

    Schetelig, J., Kröger, N-M., Held, T. K., Christian, T., Krusch, A., Zabelina, T., Dubiel, M., Rick, O., Bornhäuser, M., Ehninger, G., Zander, A. & Siegert, W., 2002, In: HAEMATOLOGICA. 87, 3, p. 299-305 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.

    Kröger, N-M., Schwerdtfeger, R., Kiehl, M., Sayer, H. G., Renges, H-H., Zabelina, T., Fehse, B., Tögel, F., Wittkowsky, G., Kuse, R. & Zander, A., 2002, In: BLOOD. 100, 3, p. 755-760 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Binding of activated platelets to WBCs in vivo after transfusion.

    Gutensohn, K., Geidel, K., Brockmann, M., Siemensen, M., Krueger, W., Kröger, N. & Kuehnl, P., 2002, In: TRANSFUSION. 42, 10, p. 1373-1380 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.

    Hessling, J., Kröger, N-M., Werner, M., Zabelina, T., Hansen, A., Kordes, U., Ayuketang Ayuk, F., Renges, H-H., Panse, J., Erttmann, R. & Zander, A., 2002, In: BRIT J HAEMATOL. 119, 3, p. 769-772 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses.

    Gutensohn, K., Geidel, K., Kröger, N., Eifrig, B., Crespeigne, N. & Kuehnl, P., 2002, In: TRANSFUS APHER SCI. 26, 3, p. 147-155 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Radiotherapy after high-dose chemotherapy and peripheral blood stem cell support in high-risk breast cancer.

    Hoeller, U., Juergen, H., Kröger, N., Krueger, W., Jaenicke, F. & Alberti, W., 2002, In: INT J RADIAT ONCOL. 53, 5, p. 1234-1239 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2000

  26. Extracorporeal plateletpheresis induces the interaction of activated platelets with white blood cells.

    Gutensohn, K., Alisch, A., Krueger, W., Kröger, N. & Kuehnl, P., 2000, In: VOX SANG. 78, 2, p. 101-105 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 1999

  28. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients.

    Dürken, M., Horstmann, M., Bieling, P., Erttmann, R., Kabisch, H., Löliger, C., Schneider, E. M., Hellwege, H. H., Krüger, W., Kröger, N., Zander, A. R. & Janka, G. E., 01.09.1999, In: BRIT J HAEMATOL. 106, 4, p. 1052-1058 7 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products.

    Gutensohn, K., Carrero, I., Krueger, W., Kröger, N., Schäfer, P., Luedemann, K. & Kuehnl, P., 1999, In: TRANSFUSION. 39, 11-12, p. 1220-1226 11-12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 1998

  31. Purging and haemopoietic progenitor cell selection by CD34+ cell separation

    Krüger, W., Gruber, M., Hennings, S., Fehse, N., Fehse, B., Gutensohn, K., Kröger, N. & Zander, A. R., 04.1998, In: BONE MARROW TRANSPL. 21, 7, p. 665-671 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

    Lehnert, M., Mross, K., Schueller, J., Thuerlimann, B., Kröger, N. & Kupper, H., 1998, In: BRIT J CANCER. 77, 7, p. 1155-1163 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. 1991

  34. Metolazone in der Behandlung fortgeschrittener therapieresistenter dilatativer Kardiomyopathie

    Kröger, N., Szuba, J. & Frenzel, H., 15.06.1991, In: MED KLIN-INTENSIVMED. 86, 6, p. 305-8, 332

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 1990

  36. Metolazone for severe dilated cardiomyopathy refractory to conventional therapy

    Kröger, N., Szuba, J., Buhl, C., Pompecki, R. & Frenzel, H., 28.04.1990, In: LANCET. 335, 8696, p. 1031-2 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...12 13 14 15 16 Next